Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.08% Nasdaq Down0.83%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
14.61 Down 0.30(2.01%) 4:00PM EDT
- Nasdaq Real Time Price
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 8,783   8,709   8,319   8,068  
Cost of Revenue -   -   -   -  
Gross Profit 8,783   8,709   8,319   8,068  
Operating Expenses
Research Development6,222  8,026  5,982  7,960  
Selling General and Administrative9,851  5,711  5,074  3,958  
Non Recurring -   -   -   -  
Others377  377  372  369  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (7,667) (5,405) (3,109) (4,219)
Income from Continuing Operations
Total Other Income/Expenses Net44  25  30  46  
Earnings Before Interest And Taxes(7,623)(5,380)(3,079)(4,173)
Interest Expense -   -   -   -  
Income Before Tax(7,623)(5,380)(3,079)(4,173)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(7,623)(5,380)(3,079)(4,173)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (7,623) (5,380) (3,079) (4,173)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (7,623) (5,380) (3,079) (4,173)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.